| Stem definition | Drug id | CAS RN |
|---|---|---|
| interleukin-2 analogues and derivatives | 5087 | 173146-27-5 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
more potent, truncated form of DAB(486)-IL-2; inhibit HIV-1 RNA production in infected cells
|
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Feb. 5, 1999 | FDA | EISAI INC | |
| March 23, 2021 | PMDA | Eisai Co., Ltd. |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | L01XX29 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS Other antineoplastic agents |
| FDA CS | M0006522 | Diphtheria Toxin |
| FDA CS | M0011506 | Interleukin-2 |
| FDA CS | M0018640 | Recombinant Fusion Proteins |
| MeSH PA | D000970 | Antineoplastic Agents |
| FDA EPC | N0000177912 | CD25-directed Cytotoxin |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Refractory peripheral T-cell lymphoma | indication | 109977009 | |
| Primary cutaneous T-cell lymphoma | indication | 400122007 |
None
None
None
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Interleukin-2 receptor | Membrane receptor | ANTIBODY BINDING | DRUG LABEL | DRUG LABEL |
| ID | Source |
|---|---|
| 25E79B5CTM | UNII |
| D03682 | KEGG_DRUG |
| C0717670 | UMLSCUI |
| CHEMBL1201550 | ChEMBL_ID |
| DB00004 | DRUGBANK_ID |
| 7680 | INN_ID |
| C078456 | MESH_SUPPLEMENTAL_RECORD_UI |
| 7044 | IUPHAR_LIGAND_ID |
| 214470 | RXNORM |
| 14092 | MMSL |
| 7958 | MMSL |
| d04386 | MMSL |
| 007748 | NDDF |
| 125700002 | SNOMEDCT_US |
| 398881002 | SNOMEDCT_US |
None